Matthew P. Kowalsky

Chief Administrative Officer at SIGILON THERAPEUTICS, INC.

Net worth: - $ as of 31/07/2023

52 year

Health Technology

Consumer Services

Profile

Matthew P.
Kowalsky is currently the Secretary & Chief Legal Officer at Sigilon Therapeutics, Inc. He previously worked as Assistant General Counsel at ARIAD Pharmaceuticals, Inc. and Lantheus Medical Imaging, Inc. He also worked as Associate General Counsel at Cubist Pharmaceuticals LLC and Senior Corporate Counsel at Genzyme Corp.
Before joining Sigilon Therapeutics, Inc., he was the Secretary & Vice President-Legal at Proteon Therapeutics, Inc. Mr. Kowalsky received his undergraduate degree from the University of Notre Dame and his graduate degree from the University of Notre Dame The Law School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SIGILON THERAPEUTICS, INC. -.--%	11/08/2023	0 ( -.--% )	- $	31/07/2023

Matthew P. Kowalsky active positions

Companies	Position	Start
SIGILON THERAPEUTICS, INC.	Chief Administrative Officer	-

All active positions of Matthew P. Kowalsky

Former positions of Matthew P. Kowalsky

Companies	Position	End
PROTARA THERAPEUTICS, INC.	General Counsel	01/01/2019
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/05/2016
CUBIST PHARMACEUTICALS INC	General Counsel	01/01/2015
ARIAD PHARMACEUTICALS, INC.	General Counsel	01/11/2013
Lantheus Medical Imaging, Inc. Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA.	General Counsel	01/01/2013

See the detail of Matthew P. Kowalsky's experience

Training of Matthew P. Kowalsky

University of Notre Dame	Undergraduate Degree
University of Notre Dame The Law School	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew P. Kowalsky's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SIGILON THERAPEUTICS, INC.	Health Technology

Private companies	5
ARIAD Pharmaceuticals, Inc. ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA.	Health Technology
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA.	Health Technology
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Proteon Therapeutics, Inc. Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.	Health Technology
Lantheus Medical Imaging, Inc. Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA.	Health Technology